Brussels, Belgium

Maryse Brait




Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maryse Brait: Innovator in Heme Binding Protein Research

Introduction

Maryse Brait is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of biochemistry, particularly in the study of heme binding proteins. With a total of 3 patents, her work has implications for understanding and treating various diseases.

Latest Patents

One of her latest patents is titled "Nucleic acids encoding a heme binding protein polypeptide." This invention relates to methods, reagents, and kits for detecting formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample. It also identifies agents that modulate this polypeptide activity. Additionally, it includes antibodies raised against FPRL2 and substances aimed at preventing, treating, and alleviating diseases characterized by dysregulation of FPRL2 polypeptide signaling. Another significant patent is "Ligand for G-protein coupled receptor FPRL2," which shares similar methodologies and applications as her previous work.

Career Highlights

Throughout her career, Maryse has worked with notable companies, including Euroscreen S.A. Her innovative research has positioned her as a key figure in her field, contributing to advancements in medical science.

Collaborations

Maryse has collaborated with esteemed colleagues such as Isabelle Migeotte and Marc Parmentier. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Maryse Brait's contributions to the field of biochemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in understanding heme binding proteins and their applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…